Insights

Strong Market Presence Amneal Pharmaceuticals has a diversified portfolio of over 290 products across generics, biosimilars, injectables, and specialty medicines, enabling access to a broad range of healthcare providers and patient populations, which presents opportunities for expanding product lines or cross-selling related therapies.

Recent Product Launches The recent launch of BORUZU, a novel oncology drug, demonstrates Amneal's focus on advancing its specialty medicines portfolio, offering potential sales avenues within the rapidly growing oncology market.

Manufacturing Expansion Partnerships like the collaboration with ApiJect Systems to enhance sterile and Blow-Fill-Seal capabilities indicate ongoing capacity and process innovations, providing opportunities to supply new or upcoming sterile medical products.

Recognition and Growth Being named a 2026 biospace best place to work and holding an impressive revenue range of up to $10 billion suggests a stable, growing organization that values quality and innovation, making it a reliable partner for long-term business development opportunities.

Financial Capacity With over $2.4 billion in funding and a substantial revenue base, Amneal has significant financial resources to invest in new initiatives, collaborations, or key account agreements, opening doors for strategic partnership and expansion opportunities.

Amneal Pharmaceuticals Tech Stack

Amneal Pharmaceuticals uses 8 technology products and services including Facebook Pixel, SQL, Apple iCloud Mail, and more. Explore Amneal Pharmaceuticals's tech stack below.

  • Facebook Pixel
    Analytics
  • SQL
    Database
  • Apple iCloud Mail
    Email
  • Veeva Vault
    Enterprise Content Management
  • Kinsta
    Platform As A Service
  • On-Site
    Real Estate Property Management
  • MediaElement.js
    Video Players
  • Google Analytics
    Web Analytics

Media & News

Amneal Pharmaceuticals's Email Address Formats

Amneal Pharmaceuticals uses at least 1 format(s):
Amneal Pharmaceuticals Email FormatsExamplePercentage
First.Last@amneal.comJohn.Doe@amneal.com
56%
FLast@amneal.comJDoe@amneal.com
24%
FirstL@amneal.comJohnD@amneal.com
13%
First@amneal.comJohn@amneal.com
7%

Frequently Asked Questions

Where is Amneal Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's main headquarters is located at 400 Crossing Boulevard Bridgewater, New Jersey 08807 United States. The company has employees across 6 continents, including AsiaNorth AmericaEurope.

What is Amneal Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Amneal Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amneal Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals is a publicly traded company; the company's stock symbol is AMRX.

What is Amneal Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's official website is amneal.com and has social profiles on LinkedInCrunchbase.

How much revenue does Amneal Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of March 2026, Amneal Pharmaceuticals's annual revenue is estimated to be $1B.

What is Amneal Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Amneal Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of March 2026, Amneal Pharmaceuticals has approximately 7K employees across 6 continents, including AsiaNorth AmericaEurope. Key team members include Chief Scientific Officer: S. K.Chief Quality Officer: S. K. J.Chief Corporate Development Officer: G. S.. Explore Amneal Pharmaceuticals's employee directory with LeadIQ.

What industry does Amneal Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Amneal Pharmaceuticals use?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's tech stack includes Facebook PixelSQLApple iCloud MailVeeva VaultKinstaOn-SiteMediaElement.jsGoogle Analytics.

What is Amneal Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals's email format typically follows the pattern of First.Last@amneal.com. Find more Amneal Pharmaceuticals email formats with LeadIQ.

How much funding has Amneal Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of March 2026, Amneal Pharmaceuticals has raised $2.4B in funding. The last funding round occurred on Nov 16, 2023 for $2.4B.

When was Amneal Pharmaceuticals founded?

Minus sign iconPlus sign icon
Amneal Pharmaceuticals was founded in 2002.

Amneal Pharmaceuticals

Pharmaceutical ManufacturingNew Jersey, United States5001-10000 Employees

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is guided by a simple belief: essential medicines should be accessible to everyone. What began as a promise to deliver high-quality, affordable medicines has evolved into a diversified portfolio spanning complex generics and injectables, biosimilars, and specialty medicines, including more than 290 products, with scale and capabilities that help reach patients across the healthcare system while combining world-class precision with a deep sense of personal responsibility for every dose we deliver. 

Content is for informational purposes only and 3rd party content does not reflect Amneal’s opinions. 

Amneal has the right to remove comments that violate another’s copyright or intellectual property, mention an Amneal product, use profanity or are defamatory, promote and solicit for third-party sites, initiatives, or products, or are factually inaccurate or misleading or spam. 

Amneal recommends that you consult with your healthcare provider regarding personal health matters. To report a product complaint or adverse event related to an Amneal product, contact Drug Safety at 877-835-5472, option 3 or drugsafety@amneal.com. If you are currently experiencing a life-threatening event, please immediately contact 911.

Section iconCompany Overview

Headquarters
400 Crossing Boulevard Bridgewater, New Jersey 08807 United States
Phone number
Website
amneal.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
AMRX
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
5001-10000

Section iconFunding & Financials

  • $2.4B

    Amneal Pharmaceuticals has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Nov 16, 2023 in the amount of $2.4B.

  • $1B$10B

    Amneal Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $2.4B

    Amneal Pharmaceuticals has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Nov 16, 2023 in the amount of $2.4B.

  • $1B$10B

    Amneal Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.